A patient who has BPH is taking doxazosin and finasteride.The patient asks the primary care NP whether he has an increased risk of prostate cancer.The NP should tell him:

Question

Quizplus · Accepted Answer

There is an overall reduction in prostate cancer risk for patients taking 5a-reductase inhibitors,such as finasteride,but there is an increased risk of high-grade prostate cancer.His overall cancer risk is less.Doxazosin does not affect cancer risk.

A Patient Who Has BPH Is Taking Doxazosin and Finasteride